{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:37:25Z","timestamp":1771918645279,"version":"3.50.1"},"reference-count":47,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Animals"],"abstract":"<jats:p>The role of HER2 in canine mammary tumors is not completely elucidated, and the contradictory results published so far may be, in part, explained by the genetic variability recognized in the canine HER2 gene. Single nucleotide polymorphism (SNPs) in HER2 were recently associated with less aggressive canine mammary tumor histotypes. This study assesses the relationship between SNPs rs24537329 and rs24537331 in canine HER2 gene and clinicopathological characteristics and outcome of mammary tumors in a group of 206 female dogs. Allelic variants were observed in 69.8% and 52.7% of the dogs for SNP rs24537329 and rs24537331, respectively. Our results demonstrated that SNP rs24537331 was associated with decreased tumoral necrosis (HR: 3.09; p = 0.012) and with longer disease-specific overall survival (HR: 2.59; p = 0.013). However, no statistically significant associations were found between SNP rs24537329 and the tumors\u2019 clinicopathological characteristics or survival. Our data suggest that SNP rs24537331 may have a protective effect in canine mammary tumors, allowing the identification of a subgroup of animals prone to develop less aggressive forms of the disease. This study emphasizes the importance of the genetic tests associated with clinical images and histological examinations when assessing CMT outcomes.<\/jats:p>","DOI":"10.3390\/ani13081384","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T05:18:13Z","timestamp":1681795093000},"page":"1384","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Protective Effect of HER2 Gene Polymorphism rs24537331 in the Outcome of Canine Mammary Tumors"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5770-8454","authenticated-orcid":false,"given":"Ana","family":"Canadas-Sousa","sequence":"first","affiliation":[{"name":"Department of Pathology and Molecular Immunology, Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar, ICBAS-UP, University of Porto, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1350-4254","authenticated-orcid":false,"given":"Marta","family":"Santos","sequence":"additional","affiliation":[{"name":"Department of Microscopy, Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar, ICBAS-UP, University of Porto, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8845-794X","authenticated-orcid":false,"given":"Patr\u00edcia","family":"Dias-Pereira","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Immunology, Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar, ICBAS-UP, University of Porto, 4050-313 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejphar.2009.08.045","article-title":"The effect of genetic variability on drug response in conventional breast cancer treatment","volume":"625","author":"Wiechec","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.59566\/IJBS.2011.7158","article-title":"Genetic variation and its role in malignancy","volume":"7","author":"Scott","year":"2011","journal-title":"Int. J. Biomed. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0195-5616(03)00020-2","article-title":"Canine mammary gland tumors","volume":"33","author":"Sorenmo","year":"2003","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Salas, Y., Marquez, A., Diaz, D., and Romero, L. (2015). Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002\u20132012: A Growing Animal Health Problem. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0127381"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1439-0531.2011.01816.x","article-title":"Canine mammary tumours, an overview","volume":"46","author":"Sleeckx","year":"2011","journal-title":"Reprod. Domest. Anim."},{"key":"ref_6","first-page":"439","article-title":"Population-based incidence of mammary tumours in some dog breeds","volume":"57","author":"Moe","year":"2001","journal-title":"Adv. Reprod. Dogs Cats Exot. Carniv."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Vail, D.M., Withrow, S.J., and Rodney, L. (2007). Withrow and MacEwen\u2019s Small Animal Clinical Oncology, Saunders Elsevier. [4th ed.].","DOI":"10.1016\/B978-072160558-6.50013-7"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1354\/vp.45-2-124","article-title":"Estrogens metabolism associated with polymorphisms: Influence of COMT G482a genotype on age at onset of canine mammary tumors","volume":"45","author":"Lopes","year":"2008","journal-title":"Vet. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8770","DOI":"10.1158\/0008-5472.CAN-09-1725","article-title":"Mammary tumor development in dogs is associated with BRCA1 and BRCA2","volume":"69","author":"Rivera","year":"2009","journal-title":"Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1354\/vp.08-VP-0298-D-FL","article-title":"Influence of catechol-O-methyltransferase (COMT) genotypes on the prognosis of canine mammary tumors","volume":"46","author":"Lopes","year":"2009","journal-title":"Vet. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/vco.12438","article-title":"Catechol-o-methyltransferase genotypes are associated with progression and biological behaviour of canine mammary tumours","volume":"16","author":"Canadas","year":"2018","journal-title":"Vet. Comp. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcpa.2019.08.010","article-title":"Single Nucleotide Polymorphisms Influence Histological Type and Grade of Canine Malignant Mammary Tumours","volume":"172","author":"Santos","year":"2019","journal-title":"J. Comp. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3389\/fonc.2019.01124","article-title":"Deciphering HER2 Breast Cancer Disease: Biological and Clinical Implications","volume":"9","author":"Alvarez","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Sareyeldin, R.M., Gupta, I., Al-Hashimi, I., Al-Thawadi, H.A., Al Farsi, H.F., Vranic, S., and Al Moustafa, A.E. (2019). Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer. Cancers, 11.","DOI":"10.3390\/cancers11050646"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","article-title":"Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update","volume":"142","author":"Wolff","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9083","DOI":"10.1007\/s13277-015-3661-2","article-title":"Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: Is the dog a suitable animal model for human breast cancer?","volume":"36","author":"Burrai","year":"2015","journal-title":"Tumour Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-017-4542-8","article-title":"Canine invasive mammary carcinomas as models of human breast cancer. Part 2: Immunophenotypes and prognostic significance","volume":"167","author":"Abadie","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1590\/S0100-879X2004001100013","article-title":"c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors","volume":"37","author":"Dutra","year":"2004","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.rvsc.2012.09.016","article-title":"HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome","volume":"94","author":"Ressel","year":"2013","journal-title":"Res. Vet. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Muscatello, L.V., Gobbo, F., Di Oto, E., Sarli, G., De Maria, R., De Leo, A., Tallini, G., and Brunetti, B. (2022). HER2 Overexpression and Cytogenetical Patterns in Canine Mammary Carcinomas. Vet. Sci., 9.","DOI":"10.3390\/vetsci9110583"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.tvjl.2007.10.013","article-title":"Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene","volume":"180","author":"Hsu","year":"2009","journal-title":"Vet. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00428-008-0644-3","article-title":"Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: Application of the human classification","volume":"453","author":"Gama","year":"2008","journal-title":"Virchows Arch."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/0300985813509388","article-title":"Canine mammary tumors: A review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry","volume":"51","author":"Pena","year":"2014","journal-title":"Vet. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1476-5829.2010.00250.x","article-title":"Identification of genetic variation in 11 candidate genes of canine mammary tumour","volume":"9","author":"Borge","year":"2011","journal-title":"Vet. Comp. Oncol."},{"key":"ref_25","first-page":"1","article-title":"Field blood preservation and DNA extraction from wild mammals: Methods and key factors for biodiversity studies","volume":"24","year":"2021","journal-title":"Rev. U.D.C.A Actual. Divulg. Cient\u00edfica"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/1040638718789231","article-title":"Canine mammary tumor risk is associated with polymorphisms in RAD51 and STK11 genes","volume":"30","author":"Canadas","year":"2018","journal-title":"J. Vet. Diagn. Investig."},{"key":"ref_27","unstructured":"Kiupel, M. (2019). Surgical Pathology of Tumors of Domestic Animals Volume 2: Mammary Tumors, Davis-Thompson DVM Foundation."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/0300985818806968","article-title":"Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study","volume":"56","author":"Canadas","year":"2019","journal-title":"Vet. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"ref_30","first-page":"4219","article-title":"Value of the Nottingham Histological Grading Parameters and Nottingham Prognostic Index in Canine Mammary Carcinoma","volume":"35","author":"Santos","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_31","first-page":"2","article-title":"SNP genotyping using the Sequenom MassARRAY iPLEX platform","volume":"60","author":"Gabriel","year":"2009","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Komar, A.A. (2009). Single Nucleotide Polymorphisms: Methods and Protocols, Humana Press.","DOI":"10.1007\/978-1-60327-411-1"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12282-015-0594-y","article-title":"Gene expression-based prognostic and predictive tools in breast cancer","volume":"22","year":"2015","journal-title":"Breast Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"72031","DOI":"10.18632\/oncotarget.18526","article-title":"Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis","volume":"8","author":"Cocciolone","year":"2017","journal-title":"Oncotarget"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4132\/jptm.2019.11.03","article-title":"HER2 status in breast cancer: Changes in guidelines and complicating factors for interpretation","volume":"54","author":"Ahn","year":"2020","journal-title":"J. Pathol. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.semcancer.2017.08.010","article-title":"Prognostic and predictive biomarkers in breast cancer: Past, present and future","volume":"52","author":"Nicolini","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"ref_37","unstructured":"Furrer, D., Paquet, C., Jacob, S., and Diorio, C. (2018). Cancer Prognosis, IntechOpen Limited."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6375956","DOI":"10.1155\/2020\/6375956","article-title":"Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer","volume":"2020","author":"Gaibar","year":"2020","journal-title":"J. Oncol."},{"key":"ref_39","unstructured":"Mahmut, \u00c7. (2021). Genetic Polymorphisms, IntechOpen."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2217\/fon.11.99","article-title":"The prognostic value of histological tumor necrosis in solid organ malignant disease: A systematic review","volume":"7","author":"Richards","year":"2011","journal-title":"Future Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00432-015-1997-z","article-title":"The recent progress of the mechanism and regulation of tumor necrosis in colorectal cancer","volume":"142","author":"Zhang","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jcpa.2005.10.004","article-title":"E-cadherin expression in canine malignant mammary tumours: Relationship to other clinico-pathological variables","volume":"134","author":"Matos","year":"2006","journal-title":"J. Comp. Pathol."},{"key":"ref_43","first-page":"1821","article-title":"MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: A multivariate study","volume":"26","author":"Lopes","year":"2006","journal-title":"Anticancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4917387","DOI":"10.1155\/2016\/4917387","article-title":"A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs","volume":"2016","author":"Carvalho","year":"2016","journal-title":"BioMed Res. Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/0300985817698208","article-title":"Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases","volume":"54","author":"Rasotto","year":"2017","journal-title":"Vet. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1042\/BST20170422","article-title":"Timing during translation matters: Synonymous mutations in human pathologies influence protein folding and function","volume":"46","author":"Rauscher","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/djac090","article-title":"Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment Outcomes","volume":"114","author":"Kaissarian","year":"2022","journal-title":"JNCI J. Natl. Cancer Inst."}],"container-title":["Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2615\/13\/8\/1384\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:17:57Z","timestamp":1760123877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2615\/13\/8\/1384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["ani13081384"],"URL":"https:\/\/doi.org\/10.3390\/ani13081384","relation":{},"ISSN":["2076-2615"],"issn-type":[{"value":"2076-2615","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,18]]}}}